3rd Annual Artificial Intelligence in Drug Development Congress
  • ILEC Conference Centre, 47 Lillie Road, London, United Kingdom
    SW6 1UD
  • Wednesday 25th September, 7:30am - Until Thursday 26th September, 7:00pm
Oxford Global are proud to present the 3rd Annual Artificial Intelligence in Drug Development Congress, 25 - 26 September 2019, London, UK

We will welcome over 450 artificial intelligence and pharmaceutical IT attendees representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 30 presentations, case studies and panel discussions focussed on the innovative application of artificial intelligence in drug discovery and cheminformatics, alongside machine learning in clinical trials and big data.

Including 3 Interactive Streams:

- AI in Drug Discovery and Discovery Chemistry
- Machine Learning and Personalising Patient Treatments
- AI in Big Data and Clinical Research Development

Co-located with our 17th Pharmaceutical IT Congress, SmartLabs and Laboratory Informatics Congress and Cyber Security and Data Protection in Pharma and Healthcare Congress.

14 pre-scheduled one to one meetings, exhibition spaces and informal networking opportunities


Brochure: https://go.evvnt.com/407026-0?pid=2715
Tickets: https://go.evvnt.com/407026-1?pid=2715

Tickets available from: GBP 299.0

Speakers: James Weatherall, Executive Director and Head of Advanced Analytics, AstraZeneca , Claus Bendtsen, Executive Director, AstraZeneca , Ray Liu, Senior Director and Head, Advanced Analytics and Statistical Consultation, Takeda, George Okafo, Senior Director, Insilico Drug Discovery Unit, GlaxoSmithKline, Hugo Ceulemans, Scientific Director Discovery Data Sciences, Janssen

Social Interaction
* thebestof cannot be held responsible for any changes, amends or cancellations of an event